Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the CARDIA study
Abstract Background Non-alcoholic fatty liver disease (NAFLD) is associated with cardiovascular disease (CVD) risk factors that have been linked to cognitive decline. Whether NAFLD is associated with cognitive performance in midlife remains uncertain. Methods Coronary Artery Risk Development in Youn...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-021-01681-0 |
id |
doaj-ccc557bbc9b14122857ada01d1203600 |
---|---|
record_format |
Article |
spelling |
doaj-ccc557bbc9b14122857ada01d12036002021-03-11T11:46:39ZengBMCBMC Gastroenterology1471-230X2021-03-012111910.1186/s12876-021-01681-0Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the CARDIA studyYariv Gerber0Lisa B. VanWagner1Kristine Yaffe2James G. Terry3Jamal S. Rana4Jared P. Reis5Stephen Sidney6Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv UniversityNorthwestern University Feinberg School of MedicineDepartment of Medicine, University of California San FranciscoVanderbilt University Medical CenterKaiser Permanente Northern CaliforniaNational Heart Lung and Blood InstituteKaiser Permanente Northern CaliforniaAbstract Background Non-alcoholic fatty liver disease (NAFLD) is associated with cardiovascular disease (CVD) risk factors that have been linked to cognitive decline. Whether NAFLD is associated with cognitive performance in midlife remains uncertain. Methods Coronary Artery Risk Development in Young Adults study participants with CT examination and cognitive assessment at Y25 (2010–2011; n = 2809) were included. Cognitive function was reassessed at Y30. NAFLD was defined according to liver attenuation and treated both continuously and categorically (using ≤ 40 and ≤ 51 Hounsfield units to define severity) after exclusion for other causes of liver fat. Cognitive tests including the Digit Symbol Substitution (processing speed), Rey Auditory Verbal Learning (verbal memory), and Stroop (executive function) were analyzed with standardized z-scores. Linear models were constructed to (a) examine the cross-sectional associations of NAFLD with cognitive scores and (b) evaluate its predictive role in 5-year change in cognitive performance. Results Participants’ mean age (Y25) was 50.1 (SD 3.6) years (57% female; 48% black), with 392 (14%) having mild NAFLD and 281 (10%) having severe NAFLD. NAFLD was positively associated with CVD risk factors and inversely associated with cognitive scores. However, after adjustment for CVD risk factors, no associations were shown between NAFLD and cognitive scores (all βs ≈ 0). Similarly, no associations were observed with 5-year cognitive decline. CVD history, hypertension, smoking, diabetes and hypertriglyceridemia showed stronger associations with baseline cognitive scores and were predictive of subsequent cognitive decline (all P ≤ .05). Conclusion Among middle-aged adults, inverse associations between NAFLD and cognitive scores were attenuated after adjustment for CVD risk factors, with the latter predictive of poorer cognitive performance both at baseline and follow-up.https://doi.org/10.1186/s12876-021-01681-0Non-alcoholic fatty liver diseaseCognitive performanceCardiovascular diseaseNeurological risk factorsCognitive decline |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yariv Gerber Lisa B. VanWagner Kristine Yaffe James G. Terry Jamal S. Rana Jared P. Reis Stephen Sidney |
spellingShingle |
Yariv Gerber Lisa B. VanWagner Kristine Yaffe James G. Terry Jamal S. Rana Jared P. Reis Stephen Sidney Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the CARDIA study BMC Gastroenterology Non-alcoholic fatty liver disease Cognitive performance Cardiovascular disease Neurological risk factors Cognitive decline |
author_facet |
Yariv Gerber Lisa B. VanWagner Kristine Yaffe James G. Terry Jamal S. Rana Jared P. Reis Stephen Sidney |
author_sort |
Yariv Gerber |
title |
Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the CARDIA study |
title_short |
Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the CARDIA study |
title_full |
Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the CARDIA study |
title_fullStr |
Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the CARDIA study |
title_full_unstemmed |
Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the CARDIA study |
title_sort |
non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the cardia study |
publisher |
BMC |
series |
BMC Gastroenterology |
issn |
1471-230X |
publishDate |
2021-03-01 |
description |
Abstract Background Non-alcoholic fatty liver disease (NAFLD) is associated with cardiovascular disease (CVD) risk factors that have been linked to cognitive decline. Whether NAFLD is associated with cognitive performance in midlife remains uncertain. Methods Coronary Artery Risk Development in Young Adults study participants with CT examination and cognitive assessment at Y25 (2010–2011; n = 2809) were included. Cognitive function was reassessed at Y30. NAFLD was defined according to liver attenuation and treated both continuously and categorically (using ≤ 40 and ≤ 51 Hounsfield units to define severity) after exclusion for other causes of liver fat. Cognitive tests including the Digit Symbol Substitution (processing speed), Rey Auditory Verbal Learning (verbal memory), and Stroop (executive function) were analyzed with standardized z-scores. Linear models were constructed to (a) examine the cross-sectional associations of NAFLD with cognitive scores and (b) evaluate its predictive role in 5-year change in cognitive performance. Results Participants’ mean age (Y25) was 50.1 (SD 3.6) years (57% female; 48% black), with 392 (14%) having mild NAFLD and 281 (10%) having severe NAFLD. NAFLD was positively associated with CVD risk factors and inversely associated with cognitive scores. However, after adjustment for CVD risk factors, no associations were shown between NAFLD and cognitive scores (all βs ≈ 0). Similarly, no associations were observed with 5-year cognitive decline. CVD history, hypertension, smoking, diabetes and hypertriglyceridemia showed stronger associations with baseline cognitive scores and were predictive of subsequent cognitive decline (all P ≤ .05). Conclusion Among middle-aged adults, inverse associations between NAFLD and cognitive scores were attenuated after adjustment for CVD risk factors, with the latter predictive of poorer cognitive performance both at baseline and follow-up. |
topic |
Non-alcoholic fatty liver disease Cognitive performance Cardiovascular disease Neurological risk factors Cognitive decline |
url |
https://doi.org/10.1186/s12876-021-01681-0 |
work_keys_str_mv |
AT yarivgerber nonalcoholicfattyliverdiseaseandcognitivefunctioninmiddleagedadultsthecardiastudy AT lisabvanwagner nonalcoholicfattyliverdiseaseandcognitivefunctioninmiddleagedadultsthecardiastudy AT kristineyaffe nonalcoholicfattyliverdiseaseandcognitivefunctioninmiddleagedadultsthecardiastudy AT jamesgterry nonalcoholicfattyliverdiseaseandcognitivefunctioninmiddleagedadultsthecardiastudy AT jamalsrana nonalcoholicfattyliverdiseaseandcognitivefunctioninmiddleagedadultsthecardiastudy AT jaredpreis nonalcoholicfattyliverdiseaseandcognitivefunctioninmiddleagedadultsthecardiastudy AT stephensidney nonalcoholicfattyliverdiseaseandcognitivefunctioninmiddleagedadultsthecardiastudy |
_version_ |
1724225220371283968 |